07 Compare without the noise
Put the context side by side.
Choose up to three entries to compare what they are, their evidence context, reference details, technical notes, and key cautions. This workspace supports clearer reading—it does not assess personal suitability or provide treatment guidance.
Field note Read the record before the claim
Evidence is more useful when its setting stays visible.
Use the filters to create a small, meaningful set. Then read the detailed board for the research setting, reference record, technical context, and limitations behind each name.

01 Find a useful set
Filter the guide
86 of 86 entries shown
02 Select up to three
Build your comparison set
Start with entries that answer the same question, then use the detailed board to see where their context and limitations differ.
Entries are grouped by evidence context first, then annotated with status and reference availability.
| Compare | Entry | Evidence context | Status context | Reference detail | Topic |
|---|---|---|---|---|---|
| 01PrescriptionProduct-specific approval context12 entries | |||||
| Semaglutide | Prescription | Approved product noted | Technical record | Metabolic medicines | |
| Tirzepatide | Prescription | No status context available | Reference detail | Metabolic medicines | |
| Liraglutide | Prescription | Approved product noted | Technical record | Metabolic medicines | |
| Dulaglutide | Prescription | Approved product noted | Technical record | Metabolic medicines | |
| Tesamorelin | Prescription | Approved product noted | Partial technical data | Hormone signalling | |
| HGH | Prescription | No status context available | Technical record | Hormone replacement | |
| Gonadorelin | Prescription | Approved product noted | Technical record | Reproductive hormones | |
| Oxytocin | Prescription | Approved product noted | Partial technical data | Reproductive hormones | |
| HCG | Prescription | No status context available | Technical record | Reproductive hormones | |
| PT-141 | Prescription | Approved product noted | Technical record | Sexual health | |
| Orforglipron | Prescription | No status context available | Technical record | Metabolic medicines | |
| SS-31 (Elamipretide) | Prescription | Approved product noted | Technical record | Mitochondrial medicines | |
| 02ClinicalHuman research or development9 entries | |||||
| Retatrutide | Clinical | No status context available | Reference detail | Metabolic medicines | |
| Cagrilintide | Clinical | No status context available | Technical record | Metabolic medicines | |
| Mazdutide | Clinical | Investigational | Technical record | Metabolic medicines | |
| Survodutide | Clinical | No status context available | Reference detail | Metabolic medicines | |
| Amycretin | Clinical | Investigational | Technical record | Metabolic medicines | |
| VK2735 | Clinical | Investigational | Technical record | Metabolic medicines | |
| MariTide | Clinical | Investigational | Technical record | Metabolic medicines | |
| Eloralintide | Clinical | Investigational | Technical record | Metabolic medicines | |
| ACE-083 | Clinical | Not approved | Technical record | Neuromuscular research | |
| 03Early researchEarly, limited, or preclinical evidence48 entries | |||||
| BPC-157 | Early research | No status context available | Technical record | Tissue-repair claims | |
| TB-500 | Early research | Not approved | Partial technical data | Tissue-repair claims | |
| CJC-1295 DAC | Early research | Not approved | Technical record | Hormone signalling | |
| CJC-1295 no DAC | Early research | No status context available | Technical record | Hormone signalling | |
| Ipamorelin | Early research | Not approved | Technical record | Hormone signalling | |
| GHRP-2 | Early research | No status context available | Technical record | Hormone signalling | |
| GHRP-6 | Early research | No status context available | Partial technical data | Hormone signalling | |
| Melanotan I | Early research | No status context available | Partial technical data | Pigment biology | |
| Melanotan II | Early research | No status context available | Technical record | Pigment biology | |
| MOTS-c | Early research | No status context available | Partial technical data | Mitochondrial research | |
| Selank | Early research | Not approved | Partial technical data | Neuropeptide research | |
| Semax | Early research | No status context available | Reference detail | Neuropeptide research | |
| Dihexa | Early research | No status context available | Technical record | Neurobiology research | |
| DSIP | Early research | No status context available | Partial technical data | Sleep research | |
| Thymosin Alpha-1 | Early research | Approved product noted | Technical record | Immune research | |
| AOD-9604 | Early research | Not approved | Partial technical data | Metabolic research | |
| HGH Fragment 176-191 | Early research | No status context available | No reference detail | Metabolic research | |
| Sermorelin | Early research | Approved product noted | Technical record | Hormone signalling | |
| IGF-1 LR3 | Early research | No status context available | Technical record | Growth-factor research | |
| Follistatin 344 | Early research | Not approved | Partial technical data | Muscle biology | |
| Epitalon | Early research | Not approved | Partial technical data | Circadian research | |
| KPV | Early research | No status context available | Reference detail | Inflammation research | |
| LL-37 | Early research | No status context available | Technical record | Immune research | |
| Tesofensine | Early research | Investigational | Partial technical data | Appetite research | |
| IGF-1 DES | Early research | No status context available | Technical record | Growth-factor research | |
| PEG-MGF | Early research | Not approved | Technical record | Muscle biology | |
| Thymulin | Early research | Not approved | Partial technical data | Immune research | |
| ADAMAX | Early research | No status context available | Technical record | Neuropeptide research | |
| FOXO4-DRI | Early research | Not approved | Technical record | Cell-aging research | |
| MGF (Mechano Growth Factor) | Early research | Not approved | Technical record | Muscle biology | |
| Hexarelin | Early research | Not approved | Technical record | Hormone signalling | |
| ACE-031 | Early research | No status context available | No reference detail | Muscle biology | |
| Adipotide | Early research | Not approved | Technical record | Metabolic research | |
| ARA-290 | Early research | Investigational | Technical record | Tissue-protection research | |
| Orexin-A | Early research | No status context available | Technical record | Sleep and alertness biology | |
| Pinealon | Early research | Not approved | Technical record | Neuropeptide research | |
| Thymalin | Early research | Not approved | Partial technical data | Immune research | |
| P21 | Early research | No status context available | Technical record | Neurobiology research | |
| Humanin | Early research | Investigational | Technical record | Mitochondrial research | |
| PNC-27 | Early research | No status context available | No reference detail | Cancer research | |
| Larazotide Acetate | Early research | No status context available | Partial technical data | Intestinal research | |
| PE-22-28 | Early research | Not approved | Partial technical data | Neurobiology research | |
| Thymagen | Early research | Not approved | Technical record | Immune research | |
| Vilon | Early research | No status context available | No reference detail | Immune research | |
| Cortexin | Early research | Not approved | Technical record | Neuropeptide mixture | |
| Cerebrolysin | Early research | No status context available | Partial technical data | Neuropeptide mixture | |
| Kisspeptin-10 | Early research | No status context available | Technical record | Reproductive-hormone research | |
| VIP (Vasoactive Intestinal Peptide) | Early research | No status context available | Technical record | Neuropeptide research | |
| 04Biology / contextBiology, cosmetic, or chemical context8 entries | |||||
| Snap-8 | Biology / context | Not approved | Technical record | Cosmetic peptide context | |
| AICAR | Biology / context | No status context available | Partial technical data | Small-molecule research | |
| GHK-Cu | Biology / context | No status context available | Partial technical data | Copper peptide & cosmetics | |
| NAD+ | Biology / context | No status context available | Technical record | Cellular metabolism | |
| Glutathione | Biology / context | Not approved | Partial technical data | Antioxidant biology | |
| AHK-Cu | Biology / context | Not approved | Technical record | Copper peptide & cosmetics | |
| SLU-PP-332 | Biology / context | Not approved | Technical record | Small-molecule research | |
| 5-Amino-1MQ | Biology / context | Not approved | Technical record | Small-molecule research | |
| 05CombinationNamed combinations9 entries | |||||
| Tesamorelin + CJC-1295 + Ipamorelin | Combination | No status context available | Partial technical data | Source-library combination | |
| PT-141 + Oxytocin | Combination | No status context available | Partial technical data | Source-library combination | |
| Klow Blend (BPC-157 + TB-500 + KPV + GHK-Cu) | Combination | No status context available | Partial technical data | Source-library combination | |
| CagriSema (Cagrilintide + Semaglutide) | Combination | No status context available | Partial technical data | Source-library combination | |
| CJC-1295 + Ipamorelin | Combination | No status context available | Partial technical data | Source-library combination | |
| BPC-157 + TB-500 | Combination | No status context available | Partial technical data | Source-library combination | |
| Sermorelin + Ipamorelin | Combination | No status context available | Partial technical data | Source-library combination | |
| SEMAX + SELANK | Combination | No status context available | Partial technical data | Source-library combination | |
| Glow Blend (BPC-157 + TB-500 + GHK-Cu) | Combination | No status context available | Partial technical data | Source-library combination | |
03 Read the difference
Detailed side-by-side overview
Every selected entry follows the same reading order, making differences in evidence, record quality, and cautions easier to spot.
Save and revisit your reading sets
Saved sets and viewing history are private to your signed-in account and store only public entry names.
Checking account access…
Exports include only the selected entries and their public evidence-context fields.
Comparison overview · No entries selected
to compare
to compare
to compare